Judge seems OK with Ackman's $290M Allergan settlement

Bill Ackman and Valeant Pharmaceuticals can breathe a sigh of relief -- for now. A federal judge in California indicated Tuesday that he would grant preliminary approval to a $290 million settlement Ackman's Pershing Square and Valeant reached with shareholders of Botox-maker Allergan. "The Court has vacated the trial date and indicated its preliminary approval...